| Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex N Santana, A Bortolozzi, J Serrats, G Mengod, F Artigas Cerebral cortex 14 (10), 1100-1109, 2004 | 572 | 2004 |
| Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance M Schneeberger, MO Dietrich, D Sebastián, M Imbernón, C Castaño, ... Cell 155 (1), 172-187, 2013 | 529 | 2013 |
| Co-expression and In Vivo Interaction of Serotonin1A and Serotonin2A Receptors in Pyramidal Neurons of Prefrontal Cortex M Amargós-Bosch, A Bortolozzi, MV Puig, J Serrats, A Adell, P Celada, ... Cerebral cortex 14 (3), 281-299, 2004 | 435 | 2004 |
| Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research P Celada, A Bortolozzi, F Artigas CNS drugs 27 (9), 703-716, 2013 | 380 | 2013 |
| Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action L Díaz-Mataix, MC Scorza, A Bortolozzi, M Toth, P Celada, F Artigas Journal of Neuroscience 25 (47), 10831-10843, 2005 | 354 | 2005 |
| Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis I Carballo-Carbajal, A Laguna, J Romero-Giménez, T Cuadros, J Bové, ... Nature communications 10 (1), 973, 2019 | 301 | 2019 |
| The activation of 5‐HT2A receptors in prefrontal cortex enhances dopaminergic activity A Bortolozzi, L Díaz‐Mataix, MC Scorza, P Celada, F Artigas Journal of neurochemistry 95 (6), 1597-1607, 2005 | 267 | 2005 |
| Strategies for producing faster acting antidepressants A Adell, E Castro, P Celada, A Bortolozzi, A Pazos, F Artigas Drug discovery today 10 (8), 578-585, 2005 | 179 | 2005 |
| Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects A Bortolozzi, A Castañé, J Semakova, N Santana, G Alvarado, R Cortés, ... Molecular psychiatry 17 (6), 612-623, 2012 | 146 | 2012 |
| Selective α-synuclein knockdown in monoamine neurons by intranasal oligonucleotide delivery: potential therapy for Parkinson’s disease D Alarcón-Arís, A Recasens, M Galofré, I Carballo-Carbajal, N Zacchi, ... Molecular Therapy 26 (2), 550-567, 2018 | 139 | 2018 |
| Lenti‐GDNF gene therapy protects against Alzheimer's disease‐like neuropathology in 3xTg‐AD mice and MC65 cells S Revilla, S Ursulet, MJ Álvarez‐López, M Castro‐Freire, U Perpiñá, ... CNS neuroscience & therapeutics 20 (11), 961-972, 2014 | 127 | 2014 |
| In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain A Bortolozzi, L Díaz-Mataix, M Toth, P Celada, F Artigas Psychopharmacology 191, 745-758, 2007 | 120 | 2007 |
| In vivo efflux of serotonin in the dorsal raphe nucleus of 5‐HT1A receptor knockout mice A Bortolozzi, M Amargós‐Bosch, M Toth, F Artigas, A Adell Journal of neurochemistry 88 (6), 1373-1379, 2004 | 108 | 2004 |
| Catecholamine/serotonin interactions: systems thinking for brain function and disease JG Hensler, F Artigas, A Bortolozzi, LC Daws, P De Deurwaerdère, ... Advances in pharmacology 68, 167-197, 2013 | 103 | 2013 |
| Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of α-adrenoceptors A Bortolozzi, F Artigas Neuropsychopharmacology 28 (3), 421-434, 2003 | 103 | 2003 |
| Can we increase speed and efficacy of antidepressant treatments? Part I: general aspects and monoamine-based strategies F Artigas, A Bortolozzi, P Celada European Neuropsychopharmacology 28 (4), 445-456, 2018 | 97 | 2018 |
| Acute 5-HT1A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions A Ferrés-Coy, N Santana, A Castañé, R Cortés, MC Carmona, M Toth, ... Psychopharmacology 225, 61-74, 2013 | 97 | 2013 |
| Neuronal apoptosis and reversible motor deficit in dominant‐negative GSK‐3 conditional transgenic mice R Gómez‐Sintes, F Hernández, A Bortolozzi, F Artigas, J Avila, P Zaratin, ... The EMBO journal 26 (11), 2743-2754, 2007 | 97 | 2007 |
| Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors A Bortolozzi, M Masana, L Díaz-Mataix, R Cortés, MC Scorza, JA Gingrich, ... International Journal of Neuropsychopharmacology 13 (10), 1299-1314, 2010 | 95 | 2010 |
| Selective enhacement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia M Masana, A Bortolozzi, F Artigas International Journal of Neuropsychopharmacology 14 (1), 53-68, 2011 | 82 | 2011 |
Francesc ArtigasProfessor "Ad Honorem" Inst. d'InvestigacionsBiomèdiques de Barcelona, CSIC-IDIBAPS, CIBERSAMПідтверджена електронна адреса в iibb.csic.es
